TK

Tarun Katiyar

Active Director Director DIN 06452880
DIN 06452880 First appointment Dec 2012 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 14 active board seats
Past companies 2 historical roles
Total affiliations 16 Since Dec 2012
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 19 Dec 2012
Active appointments 15
Total timeline records 16

Tarun Katiyar (DIN 06452880) has 16 recorded board appointments in Indian companies, the first from December 2012, of which 15 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2012
Rdc Diagnostic Private Limited Director · 2025 – present
Current
Onco-Life Cancer Centre Private Limited Director · 2024 – present
Current
Hospaccx Financial Advisory Llp Designated Partner · 2024 – present
Current
Hospaccx Ventures Llp Designated Partner · 2023 – present
Current
Rdc Healthcare Llp Designated Partner · 2023 – present
Current
Hospaccx Operations And Management Consulting Llp Designated Partner · 2023 – present
Current
Ghs Kotbagi Hospital Llp Designated Partner · 2023 – present
Current
Stryker Medicare Private Limited Director · 2022 – present
Current
Meduskills Private Limited Director · 2021 – present
Current
Current
Hospamplify Ventures Llp Designated Partner · 2017 – present
Current
Caremed Healthcare Private Limited Director · 2016 – present
Current
Shrivatsa Healthcare Llp Designated Partner · 2014 – present
Current
Snowtree Healthcare Private Limited Director · 2013 – present
Current
Vasudev Hospitals Private Limited Director · 2012 – 2019
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available